• Bedaquiline: Redefining Tuberculosis and Cancer Metabolism R

  2026-05-15

  Discover how Bedaquiline, a diarylquinoline antibiotic, uniquely disrupts Mycobacterium tuberculosis energy metabolism and impairs cancer stem cell function. This article offers advanced insights beyond standard workflows, including protocol guidance and a comparative evaluation of host- versus pathogen-targeted therapies.

• EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1

  2026-05-14

  EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent designed for efficient amide bond formation in in vitro peptide synthesis, bioconjugation, and nucleotide chemistry workflows. It should not be used in in vivo or clinical applications due to the absence of supporting data.

• Temozolomide in Translational Glioma Research: Mechanisms &

  2026-05-14

  This thought-leadership article explores advanced mechanistic insights and strategic considerations for deploying Temozolomide—a benchmark small-molecule alkylating agent—in DNA repair and chemotherapy resistance research, especially in the context of ATRX-deficient high-grade glioma. Integrating recent findings and best practices, it provides actionable protocol guidance, competitive positioning, and a visionary roadmap for translational researchers.

• P2RX1 Drives Mitochondrial Apoptosis in Ph+ ALL via Ca2+/CaM

  2026-05-13

  This study demonstrates that P2RX1 overexpression sensitizes Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) cells to mitochondrial apoptosis by disrupting calcium homeostasis and suppressing PI3K/Akt signaling through CaMKII activation. These mechanistic insights highlight new therapeutic targets and provide a foundation for optimized apoptosis detection workflows in leukemia research.

• Staurosporine: Strategic Kinase Inhibition in Cancer Researc

  2026-05-13

  Explore the mechanistic and translational significance of Staurosporine—a benchmark broad-spectrum serine/threonine protein kinase inhibitor—in dissecting kinase signaling, inducing apoptosis, and advancing anti-angiogenic strategies in cancer research. Drawing from recent evidence on pro-metastatic states and referencing both foundational and emerging studies, this article offers actionable protocol guidance, strategic insights, and a forward-looking perspective for translational researchers seeking to maximize reproducibility and clinical relevance.

• CX-4945 (Silmitasertib): Applied CK2 Inhibition in Cancer &

  2026-05-12

  CX-4945 (Silmitasertib) delivers precision CK2 inhibition, empowering cancer and virology researchers to dissect signaling pathways and viral-host dynamics with high reproducibility. This guide translates recent mechanistic discoveries into actionable workflows, troubleshooting strategies, and cross-domain research opportunities.

• Anlotinib Hydrochloride: Multi-Target Tyrosine Kinase Inhibi

  2026-05-12

  Anlotinib hydrochloride is a potent multi-target tyrosine kinase inhibitor with nanomolar activity against VEGFR2, PDGFRβ, and FGFR1. It robustly inhibits endothelial cell migration and capillary tube formation, showing superior anti-angiogenic efficacy to standard agents. Its favorable pharmacokinetics and safety profile make it a valuable research tool for cancer and angiogenesis studies.

• Palonosetron Hydrochloride: Precision 5-HT3 Receptor Antagon

  2026-05-11

  Palonosetron hydrochloride stands out as a highly selective 5-HT3 receptor antagonist with dual-site binding and extended receptor occupancy, enabling robust experimental designs for CINV/RINV prevention and renal transporter studies. Its sub-nanomolar potency and specificity make it a benchmark tool for translational cancer research and transporter modulation assays.

• TBK1 Inhibition Alleviates Painful Diabetic Neuropathy via M

  2026-05-11

  Liao et al. (2024) reveal that TANK-binding kinase 1 (TBK1) drives painful diabetic neuropathy (PDN) by activating microglial pyroptosis through the NF-κB/NLRP3 pathway. Their work demonstrates that TBK1 inhibition—via siRNA or amlexanox—attenuates PDN, suggesting a promising therapeutic target for diabetes-induced neuropathic pain.

• Fenipentol in Pancreatic Secretion Research: Protocols & Bes

  2026-05-10

  Fenipentol (1-Phenyl-1-pentanol) empowers advanced gastrointestinal physiology studies through its unique modulation of biliary and pancreatic secretions. This article delivers actionable workflows and troubleshooting strategies, grounded in recent network pharmacology and metabolomic insights, to maximize experimental reliability and translational value.

• Lambda Protein Phosphatase Workflows for Phosphorylation Stu

  2026-05-09

  Lambda Protein Phosphatase (RNase-free) from APExBIO empowers precise, Mn2+-dependent dephosphorylation for rigorous validation of phospho-specific antibodies and real-time studies of protein phosphorylation. Advanced troubleshooting and protocol optimization support high-confidence results, especially in dynamic systems like circadian clock research.

• Recombinant Human Oncostatin M: New Frontiers in Neuroimmune

  2026-05-09

  Explore how Recombinant Human Oncostatin M (rh-Oncostatin M) advances neuroimmune research, with unique insights into microglial activation and cytokine signaling. Discover rigorous protocol guidance and analysis not found in existing resources.

• Flubendazole (SKU B1759): Reliable Autophagy Modulation in V

  2026-05-08

  This article delivers practical, evidence-backed guidance for using Flubendazole (SKU B1759) in autophagy modulation research. We address common pain points in cell viability and cytotoxicity assays, emphasizing data reproducibility, DMSO solubility, and vendor reliability. Scenario-driven Q&A blocks provide actionable insight for laboratory scientists seeking robust assay performance.

• Tetramethylrhodamine Ethyl Ester Perchlorate for Mitochondri

  2026-05-07

  Tetramethylrhodamine ethyl ester perchlorate (TMRE) is a rhodamine-like fluorescent dye optimized for live-cell mitochondrial membrane potential assays. Its high sensitivity, low cytotoxicity, and robust accumulation in active mitochondria make it a gold standard for quantifying mitochondrial function and dysfunction across a range of biological models.

• Carboplatin: Platinum-Based DNA Synthesis Inhibitor in Cance

  2026-05-07

  Carboplatin enables researchers to dissect DNA damage responses and overcome chemoresistance across diverse preclinical oncology models. Leveraging the latest mechanistic insights, this guide details robust workflows, advanced applications, and troubleshooting strategies that maximize the translational utility of this platinum-based DNA synthesis inhibitor.

450 records 18/30 page Previous Next First page 上5页 1617181920 下5页 Last page